乐普医疗收购河南新帅克制药股份有限公司股份可行性研究报告.docx

[收购]乐普医疗：收购河南新帅克制药股份有限公司股份可行性研究报告 时间：2013年06月22日 15:16:40?中财网 收购河南新帅克制药股份有限公司股份 可行性研究报告 乐普（北京）医疗器械股份有限公司 2013年06月 目 录 第一节 项目的必要性与可行性 ··············································································· 1 一、 项目实施是 HYPERLINK /quote_.html \t _blank 乐普医疗产品多元化战略发展的必然选择 ········································· 1 二、 项目对 HYPERLINK /quote_.html \t _blank 乐普医疗未来发展将产生重大影响 ························································ 1 三、 新帅克在国内心血管药物领域的竞争优势 ························································ 2 四、 医改政策有利于心血管药物快速发展 ······························································ 2 五、 协同效应令人期待 ······················································································ 3 第二节 国内外市场分析 ························································································ 4 一、 国内外 HYPERLINK /quote_.html \t _blank 医药行业发展趋势 ············································································· 4 二、 我国化学药行业分析 ··················································································· 6 三、 新帅克核心产品市场分析 ············································································· 7 第三节 技术分析 ································································································ 14 一、 我国化学药技术发展历史 ············································································ 14 二、 我国药品审批现状 ····················································································· 15 三、 新帅克的产品创新与研发 ············································································ 15 第四节 竞争力分析 ····························································································· 17 一、 硫酸氢氯吡格雷片竞争分析 ········································································· 17 二、 复方甘草酸苷片竞争分析 ············································································ 19 三、 全身抗感染药物竞争分析 ············································································ 20 四、 其他产品竞争分析 ········································